Lepista sordida polysaccharide induces apoptosis of Hep-2 cancer cells via mitochondrial pathway

International Journal of Biological Macromolecules

Volumn 61, Issue , 2013, Pages 97-101

  Miao, Susheng ^a   Mao, Xionghui ^a   Pei, Rong ^a   Miao, Suping ^b   Xiang, Cheng ^a   Lv, Yuanjing ^a   Yang, Xianguang ^a   Sun, Ji ^a   Jia, Shenshan ^a   Liu, Yvpeng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Yangquan Normal College   (China)

Author keywords

Apoptosis; Laryngocarcinoma; Lepista sordida; Mitochondrial pathway; Polysaccharide

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; MITOCHONDRIAL ENZYME; POLYSACCHARIDE; PROTEIN BAX; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; G2 PHASE CELL CYCLE CHECKPOINT; HEP 2 CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LARYNX CARCINOMA; LEPISTA SORDIDA; M PHASE CELL CYCLE CHECKPOINT; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MUSHROOM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION;

LEPISTA SORDIDA;

APOPTOSIS; LARYNGOCARCINOMA; LEPISTA SORDIDA; MITOCHONDRIAL PATHWAY; POLYSACCHARIDE;

APOPTOSIS; BASIDIOMYCOTA; CASPASES; CELL CYCLE CHECKPOINTS; CELL SURVIVAL; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FUNGAL POLYSACCHARIDES; HEP G2 CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 84880740199     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2013.06.052     Document Type: Article

References (17)

1. Li C.L., Wu H.Z., Huang Y.P., Yang Y.F., Liu Y.W., Liu J.W. Biomedicine & Pharmacotherapy 2008, 62:401-409.
2. Roy M.K., Thalang V.N., Trakoontivakorn G., Nakahara K. British Journal of Pharmacology 2005, 145:145-155.
3. Craig W.J. Journal of the American Dietetic Association 1997, 97:S199-S204.
4. Craig W.J. American Journal of Clinical Nutrition 1999, 70:S491-S499.
5. Schwartsmann G., Ratain M.J., Cragg G.M., Wong J.E., Saijo N., Parkinson D.R., Anticancer J. Journal of Clinical Oncology 2002, 20:47-59.
6. Miao S., Mao X., Pei R., Miao S., Xiang C., Lv Y., Yang X., Sun J., Jia S., Liu Y. International Journal of Biological Macromolecules 2013, 60:235-240.
7. Tsai W.C., Rao Y.K., Lin S.S., Chou M.Y., Shen Y.T., Wu C.H., Geethangili M., Yang C.C., Tzeng Y.M. Bioorganic & Medicinal Chemistry Letters 2010, 20:6145-6148.
8. Bradford M.M. Analytical Biochemistry 1976, 72:248-254.
9. Mork C.N., Faller D.V., Spanjaard R.A. Current Pharmaceutical Design 2005, 11:1091-1104.
10. Kroemer G., Galluzzi L., Brenner C. Physiological Reviews 2007, 87:99-163.
11. Han J., Goldstein L.A., Gastman B.R., Rabinowich H. Journal of Biological Chemistry 2006, 281:10153-10163.
12. Fu Y.R., Yi Z.J., Yan Y.R., Qiu Z.Y. Mitochondrion 2006, 6:211-217.
13. Green D.R., Reed J.C. Science 1998, 281:1309-1312.
14. Nunez G., Benedict M.A., Hu Y., Inohara N. Oncogene 1998, 17:3237-3245.
15. Lavrik I.N., Golks A., Krammer P.H. Journal of Clinical Investigation 2005, 115:2665-2672.
16. Ralph S.J., Low P., Dong L., Lawen A., Neuzil J. Recent Patents on Anti-Cancer Drug Discovery 2006, 1:327-346.
17. Reed J., Miyashita T., Takayama S., Wang H.G., Sato T., Krajewski S., Aime-Sempe C., Bodrug S., Kitada S., Hanada M. Journal of Cellular Biochemistry 1996, 60:23-32.